C15H7BrF 6 N 2 OS 2 , monoclinic, P21/c (no. 14), a = 18.8292(14) Å, b = 11.4568(9) Å, c = 8.3400 (6) 
(M + 2 + H, 98%) + .
Experimental details
H atoms were placed in calculated positions and were included in the re nement in the riding model approximation. The uorine atoms of the disorderd CF 3 -group were located on a di erence Fourier map and re ned freely. chemistry as pharmacophores or auxophores possessing diverse pharmacological activities, including antibacterial [1] [2] [3] [4] [5] , anticancer [6] [7] [8] [9] [10] , antiviral [11] [12] [13] , antihypertensive [14, 15] , anti-in ammatory [16, 17] and antioxidant [18] activities. In addition, some 1,3,4-oxadiazoles are currently used as safe herbicides for crop protection [19] [20] [21] . Moreover, 1,3,4-oxadiazole derivatives are widely employed electrontransporting and hole-blocking materials in the development of organic light-emitting diodes (OLEDs) [22] . The asymmetric unit cell of the title compound contains one independent molecule. The oxadiazole ring (O1/C5/N1/N2/C6)) makes dihedral angles 7.74°and 81.39°w ith the bromothiophene moiety (S1/C1-C4) and phenyl moiety (C8-C13), respectively. The tri uromethyl group is disordered over two sets of sites in a 0.736 : 0.379 ratio. The molecules packed in the crystal structure without any intermolecular hydrogen bonds.
